-
Mashup Score: 16Widening care gap in VAD therapy - 4 month(s) ago
The removal of the HeartWare ventricular assist device (HVAD) due to pump malfunctions and inferior outcomes compared to HeartMate 3 (HM3) in adults has created a care gap for younger patients. It is unclear if the reported HVAD survival differs by age and if the initial experience with HM3 can bridge the gap.
Source: www.jhltonline.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 7Intermacs quarterly report analysis to monitor longitudinal outcomes in a centrifugal flow assist device - 6 month(s) ago
In June 2021, HVAD System distribution ceased due to observational data demonstrating increased mortality and neurological events compared to another commercial device, and a device malfunction with delay or failure to restart, especially in certain subpopulations. To assess ongoing risk for patients on support following subsequent device recalls, the manufacturer’s Intermacs HVAD System 2022 Quarterly Reports were queried to identify mortality and adverse events trends in a contemporary cohort of 3110 primary HVAD implantations since October 2017, stratified by year-of-implant.
Source: www.jhltonline.orgCategories: General Medicine News, Cardiology News and JournTweet-
INTERMACS analysis shows following #HVAD market withdrawal, there appears to be no increase in mortality, stroke, pump thrombus, or explant for HVAD-supported patients. @lisong2003 đź”—https://t.co/95dgjijEbu
-
-
Mashup Score: 0
May 18 is National HIV Vaccine Awareness Day
Source: www.cdc.govCategories: HIV/AIDS, Latest HeadlinesTweet-
Today on #HVAD, we recognize the volunteers, community members, and researchers working to develop a safe and effective vaccine to prevent #HIV. Thank you for your contributions! Discover how you can get involved and share your support! via @CDCgov https://t.co/hCiAxO5CoP https://t.co/kryfEDNM5i
-
-
Mashup Score: 3HIV Vaccine Industry Partnership Group - 11 month(s) ago
The HIV Vaccine Industry Partnership Group is establishing a forum to bring about the full contribution of the biomedical industry to address the complexities of HIV vaccine R&D. Its goal is to reignite the interest of the biomedical industry, funders and academics in the search for an HIV vaccine by regaining the pharmaceutical industry’s confidence in what is now a publicly led effort. In a…
Source: www.iasociety.orgCategories: HIV/AIDS, Latest HeadlinesTweet-
The IAS HIV Vaccine Industry Partnership Group works to reignite the interest of the biomedical industry, funders and academics in the search for an #HIVvaccine. Learn more about this critical work & view recent case studies! #HVAD https://t.co/5VU0szGNrv
-
-
Mashup Score: 1
18 May 2023 (Gene
Source: www.iasociety.orgCategories: HIV/AIDS, Latest HeadlinesTweet-
Between 2019 and 2020, European funding for HIV preventative vaccine R&D decreased by 31%, significantly undermining pathways to an effective vaccine. On #HVAD, join us in calling on Europe to step up & scale up funding for HIV vaccine research! https://t.co/FY8hFLBRzn https://t.co/rTfeNHqvGt
-
-
Mashup Score: 0
18 May 2023 (Gene
Source: www.iasociety.orgCategories: HIV/AIDS, Latest HeadlinesTweet-
IAS is committed to ending #HIV as a threat to public health & individual well-being, and we call for far greater funding toward the development of an HIV vaccine to make that a reality. Find out more in our HIV Vaccine Awareness Day (#HVAD) statement: https://t.co/qwKOhUHJmZ
-
-
Mashup Score: 1Right Atrial Compression From Biodebris Associated With Long-Term Left Ventricular Assist Device Support: - 1 year(s) ago
Abstract Biodebris surrounding HVAD (Medtronic) intrapericardial centrifugal-flow left ventricular assist device outflow cannulas is common and appears to accumulate over time. We recently encounte…
Source: JACC: Case ReportsCategories: Expert Picks, Latest HeadlinesTweet-
Extreme biodebris accumulation resulting in RA compression, a potential mechanism of hemodynamic compromise in patients on long-term #HVAD support. https://t.co/xxNfYhpixS #JACCCaseReports #CHF #CardioTwitter @sarakwiat https://t.co/ZmSLB7t0II
-
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - Upcoming Webinars - 1 year(s) ago
Review of the HVAD Landscape Since June 2021 13 December, 2022 | 3:00 p.m. EDT More than a year has passed since Medtronic announced their decision to stop the distribution and sale of the HeartWare™ HVAD™ System. Our distinguished faculty will discuss the current HVAD landscape to include an update on HVAD patent management best practices and the UNOS policy change. FACULTY: Diyar Saeed, MD,…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Next week: #ISHLT & @MDT_Cardiac will review the #HVAD landscape since the end of the distribution and sale of the HeartWare™ system. You'll learn from expert faculty, PLUS get a patient's perspective. Register now to attend live or watch the recording: https://t.co/fGjaAZi0JF https://t.co/ytXkxmip2Y
-
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - Upcoming Webinars - 1 year(s) ago
Review of the HVAD Landscape Since June 2021 13 December, 2022 | 3:00 p.m. EDT More than a year has passed since Medtronic announced their decision to stop the distribution and sale of the HeartWare™ HVAD™ System. Our distinguished faculty will discuss the current HVAD landscape to include an update on HVAD patent management best practices and the UNOS policy change. FACULTY: Diyar Saeed, MD,…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
This webinar in two weeks features expert faculty surveying the #HVAD landscape since last year's changes, plus a patient perspective. Register now to attend live or get the recording: https://t.co/fGjaAZiyzd #MCS #MechanicalCirculatorySupport #VAD https://t.co/IuLvNWEFRC
-
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - Upcoming Webinars - 1 year(s) ago
Review of the HVAD Landscape Since June 2021 13 December, 2022 | 3:00 p.m. EDT More than a year has passed since Medtronic announced their decision to stop the distribution and sale of the HeartWare™ HVAD™ System. Our distinguished faculty will discuss the current HVAD landscape to include an update on HVAD patent management best practices and the UNOS policy change. FACULTY: Diyar Saeed, MD,…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
13 December: #ISHLT & @MDT_Cardiac webinar will review the #HVAD landscape since the end of the distribution and sale of the HeartWare™ system. Learn from expert faculty, PLUS a patient perspective. Register now to attend live or watch the recording: https://t.co/fGjaAZzBBd https://t.co/F8OvicFkBq
-
The abrupt removal of the #HVAD may have widened the care gap and impacted outcomes, particularly among young adults who may now have limited access to intracorporeal support. @jen_conway1 đź”— https://t.co/OuGtbL0Vn8